“公司‘大输液’板块全球领先,抗生素全产业链拥有行业话语权,新药研发进入中国医药行业第一方阵。湖南科伦制药有限公司(以下简称”湖南科伦“)董事长、省十二届人大代表,被业界称为”少帅“的刘思川这样设想科伦的未来。刘思川工作伊始就坚持用创新引领企业发展。2007年,他从英国名校毕业后进入科伦,从事基层营销工作。两年后,他就任科伦药业营销副总经理 ”The Company’s infusion unit has the world’s leading position in the antibiotic industry chain and has entered the first phalanx of China’s pharmaceutical industry. Chairman of Hunan Cologne Pharmaceutical Co., Ltd. (hereinafter referred to as“ Cologne Hunan ”) Liu Si-chuan, who is called the “less handsome” by the industry, conceives Coron’s future in this way.Liu Si-chuan insisted on using innovation to lead the development of the enterprise at the beginning of his career. In 2007, after graduating from a British elite, he entered Kelun, engaged in marketing at the grassroots level.After two years, he became Coron Pharmaceutical Marketing Deputy General Manager